A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia

Clinical trial NCT01110421 · TERMINATED

Trial details

NCT number: NCT01110421
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumonia, Bacterial Community-Acquired Infections Nosocomial Infection Pneumonia, Ventilator-Associated

Start date: 2010-12-01
Primary completion: 2012-03-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.